Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1470 of 6351
-
AI glasses could help blind people navigate the world
Symptom relief Not yet recruitingVisual impairment, particularly from glaucoma and retinal dystrophies, significantly hinders mobility and increases the risk of falls, leading to decreased independence and mental health challenges. Current low-vision assistive technologies primarily focus on near-task magnificat…
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Ultrasound-Enhanced gel and nerve stretching may ease diabetic foot pain
Symptom relief CompletedCerebral palsy is a neurological condition that affects movement, muscle control, and walking ability in children. Children with bilateral spastic cerebral palsy often experience increased muscle stiffness, difficulty with walking, reduced balance, and limited functional mobility…
Sponsor: Syeda Khatoon e Jannat Welfare Foundation • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
New pill takes on advanced cancers in early human trial
Disease control Not yet recruitingThis study is an open-label, dose-escalation, multicenter Phase I/II study conducted in patients with advanced solid tumors. The target population for this study consists of patients with advanced solid tumors who have failed or are intolerant to standard treatments. The study is…
Phase 1/2 • Sponsor: Evopoint Biosciences Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New combo aims to fix Chemo-Caused low platelets
Disease control Not yet recruitingObjective To evaluate the efficacy and safety of hetrombopag plus rhTPO versus hetrombopag monotherapy for CTIT in solid-tumor patients. Participants 204 histologically- or cytologically-confirmed solid-tumor patients with ≥grade 3 thrombocytopenia following anti-cancer treatmen…
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New hope for hidden arthritis: drug trial targets pain without X-Ray signs
Disease control Not yet recruitingSubjects who have signed the informed consent form will undergo examinations and assessments according to the inclusion/exclusion criteria specified in the trial protocol. After screening and successful enrollment, they will enter the treatment period. Dosing time points are (W0,…
Phase 2/3 • Sponsor: Lingli Dong • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New mapping tech aims to stop AFib in its tracks
Disease control Recruiting nowThe goal of this pilot study is to test if noninvasive global mapping can guide catheter ablation defining personalized targets and improve the therapy of atrial fibrillation. It will also test the safety of such an approach. The main questions it aims to answer are: * Does abla…
Sponsor: Hospital Clinic of Barcelona • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New study aims to stop postpartum bleeding in At-Risk moms
Prevention Not yet recruitingPostpartum hemorrhage (PPH) is a leading cause of maternal morbidity and mortality worldwide, particularly among women with known risk factors. Uterotonic agents are routinely administered after vaginal delivery to prevent excessive bleeding. Carbetocin, a long-acting oxytocin an…
Sponsor: Western Galilee Hospital-Nahariya • Aim: Prevention
Last updated Jun 27, 2026 08:12 UTC
-
New drug cocktail aims to fight lung cancer in the brain
Disease control Recruiting nowThis is a clinical trial that aims to test Zorifertinib when used together with a known drug, Osimertinib. The goal is to learn if this combination is safe and works for people with advanced Non-Small Cell Lung Cancer (NSCLC) whose cancer has spread to the membranes surrounding t…
Phase 1 • Sponsor: Alpha Biopharma (Jiangsu) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Could a single chemo drug replace the standard doublet for some ovarian cancers?
Disease control Not yet recruitingPlatinum-based neoadjuvant chemotherapy (NACT) followed by interval debulking surgery is a crucial treatment paradigm for advanced ovarian cancer. It can reduce tumor burden, increase the rate of R0 resection, and decrease surgical complications. The combination of paclitaxel and…
Phase 2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Weekly shot may beat daily shots for blood recovery after transplant
Disease control Recruiting nowThis study is for adults aged 18-65 with myelodysplastic syndrome (MDS) or severe aplastic anemia (AA) who are scheduled to receive a donor stem cell transplant (allogeneic hematopoietic stem cell transplant). After the transplant, it is critical for the body to start making its …
Phase 2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Engineered macrophages take on Hard-to-Treat cancers
Disease control Not yet recruitingThis is a single-arm, open-label, single-center, dose-escalation platform clinical trial design. Using an adenovirus vector platform, the study aims to evaluate the safety, tolerability, pharmacokinetic characteristics, and preliminary anti-tumor activity of investigational CAR-M…
Early phase 1 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
ER iron infusion could get anemic kids home faster
Symptom relief Not yet recruitingThe goal of this project is to assess the feasibility, clinical effectiveness, and cost-effectiveness of IV iron therapy using ferric carboxymaltose (FCM) as a treatment for pediatric patients with iron deficiency anemia (IDA) in the emergency department (ED). The primary object…
Phase 4 • Sponsor: Children's Hospital of Orange County • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
Can pressurized oxygen soothe chemo nerve pain?
Symptom relief Not yet recruitingThe goal of this research is to assess whether hyperbaric oxygen therapy can alleviate the symptoms of Nab-paclitaxel-induced peripheral neuropathy and improve patient-reported quality of life.
Phase 2/3 • Sponsor: Guangdong Provincial People's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
New drug duo targets tough cancers in early trial
Disease control Recruiting nowThis is a multicenter, open-label Phase I/II clinical study to evaluate the safety, tolerability, pharmacokinetics, and efficacy of the anti-EGFR/c-Met bispecific antibody MCLA-129 in combination with Ensartinib hydrochloride in patients with advanced solid tumors.
Phase 1/2 • Sponsor: Betta Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New rabies shot could shield millions after bites
Prevention Not yet recruitingA Phase II, Single-Center, Randomized, Blinded, Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacodynamics of a Recombinant Human Anti-Rabies Virus Monoclonal Antibody Injection in Healthy Subjects
Phase 2 • Sponsor: Lanzhou Institute of Biological Products Co., Ltd • Aim: Prevention
Last updated Jun 27, 2026 09:09 UTC
-
New combo therapy aims to shrink untreatable liver tumors
Disease control Recruiting nowThis study is a prospective, single-arm, single-center trial evaluating the efficacy of TACE combined with multimodal ablation, Tislelizumab, and lenvatinib in the treatment of unresectable primary liver cancer.
Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Which wound closure cuts infection risk after abdominal surgery?
Disease control Recruiting nowSurgical site infection (SSI) is one of the most common postoperative complications following elective laparotomy and contributes significantly to patient morbidity, prolonged hospital stay, and increased healthcare costs. Various techniques are available for skin closure, includ…
Sponsor: Pakistan Institute of Medical Sciences • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New hope for stomach cancer: immunotherapy combo targets resistant tumors
Disease control Not yet recruitingdMMR/MSI-H is a key molecular subtype of gastric cancer, found in 8-22% of cases. It is typically associated with older age, female sex, distal tumor location, and intestinal histology (Lauren classification). While this subtype predicts better survival in locally advanced diseas…
Phase 2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Brain pacemaker gets smarter to stop freezing in Parkinson's
Symptom relief By invitation onlyThe goal of this clinical trial is to learn if adaptive deep brain stimulation (DBS) can decrease or prevent freezing of gait in participants with Parkinson's disease.
Sponsor: Doris Wang, MD, PhD • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
Could a simple steroid prevent strokes after brain aneurysm stenting?
Disease control Not yet recruitingStudy Title: Testing Methylprednisolone to Prevent Strokes After a Stent Procedure for Brain Aneurysms What is the purpose of this study? This study aims to find out if a short course of a steroid medicine called methylprednisolone can help prevent strokes and other brain-relate…
Phase 4 • Sponsor: Duan Chuanzhi • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC